Projects per year
Project Details
Description
This is a double blind study of an oral agent to be used in the treatment of Alzheimer's Disease. It is a multicenter, parallel group, placebo controlled study of safety and efficacy at doses of 25,50 or 75 mgm TID in patients with mild to moderate dementia.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/95 → 9/30/99 |
Funding
- National Center for Research Resources
ASJC Scopus Subject Areas
- Clinical Neurology
- Neurology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 0 Finished
-
GENERAL CLINICAL RESEARCH CENTER
Tapley, D. (PI), Morris, T. (PI), Colten, H. (PI) & Al-Awqati, Q. (CoPI)
National Center for Research Resources
12/1/84 → 9/29/06
Project: Research project